Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H19NO6P2 |
| Molecular Weight | 287.1871 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(=O)C(NC1CCCCCC1)P(O)(O)=O
InChI
InChIKey=LWRDQHOZTAOILO-UHFFFAOYSA-N
InChI=1S/C8H19NO6P2/c10-16(11,12)8(17(13,14)15)9-7-5-3-1-2-4-6-7/h7-9H,1-6H2,(H2,10,11,12)(H2,13,14,15)
Incadronate (Disodium Cycloheptylaminomethylene diphosphate) is used to treat malignancy-associated hypercalcemia (MAH) in Japan. Experiments on rodents have revealed that this drug could be an effective agent for the treatment of various arthritic conditions, including human rheumatoid arthritis. In addition was shown, that incadronate induced growth inhibition and apoptotic death of pancreatic cancer cells. Incadronate also inhibited migration presumably by preventing the activation of Rho by lysophosphatidic acid. Thus, this drug can be of value in regimens for the treatment of pancreatic cancer.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Hydronium (cycloheptylammonio)methylene-1,1-bisphosphonate (hydronium incadronate). | 2003 Feb |
|
| The protective effects of incadronate on inflammation and joint destruction in established rat adjuvant arthritis. | 2006 Jun |
|
| Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells. | 2007 Mar-Apr |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C443
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
||
|
NCI_THESAURUS |
C67439
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
723271
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
124351-85-5
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
Incadronic acid
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
1431
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
C65906
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
G5C4M8847E
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
SUB08163MIG
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL53950
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
m6239
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID90154283
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
DB06255
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
7122
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
3699
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY | |||
|
100000083386
Created by
admin on Fri Dec 15 16:38:45 UTC 2023 , Edited by admin on Fri Dec 15 16:38:45 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
